Eric M. Ransom

Eric M. Ransom

Auto-generated profile, based on publicly available information

Eric M. Ransom

University Hospitals Cleveland Health

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
EREric M. Ransom
Eric M. Ransom
CBCarey-Ann D. Burnham
Carey-Ann D. Burnham
The utility of anaerobic blood culture bottles remains controversial, especially for specimens from children. Data are limited on the inclusion of an anaerobic bottle as part of a blood culture “set” when using contemporary blood culture instruments and media.

19 February 2025 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
EREric M. Ransom
Eric M. Ransom
MWMeghan A. Wallace
Meghan A. Wallace
Nathan WiederholdNathan Wiederhold
Nathan Wiederhold
CCConnie Cañete-Gibas
Connie Cañete-Gibas
CBCarey-Ann D. Burnham
Carey-Ann D. Burnham
Rapid and accurate identification of cultured molds is important to determine clinical significance and therapeutic decision-making. Conventional mold identification uses phenotypic macroscopic and microscopic characterization; however, this can take days or weeks for colony maturity and definitive microscopic structure formation, be limited to genus-level identification, and be misidentified due to morphologic mimics or similarities between closely related species. Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI–TOF MS) revolutionized bacterial and yeast identification but remains uncommon for molds in part because of limited reference libraries. Here, a retrospective 5-year review at a large teaching hospital found that 88.6% of identified molds were in the Bruker Filamentous Fungi Library 3.0 and 91.5% in the VITEK Knowledge Base Library 3.2.0. A prospective evaluation was also performed on early growth from 205 consecutive, working clinical isolates. Each mold was processed using the VITEK chemical extraction method and modified NIH chemical plus bead-beating extraction method; both extractions were tested on both systems. When compared to conventional identification, more molds were identified using VITEK extractions over NIH extractions using the VITEK (65 and 59%) and Bruker (56 and 54%) systems, respectively, using the ≥1.5 log Bruker threshold. VITEK MS identified more molds, regardless of the extraction method. Isolates without consensus agreement ( n = 116) underwent sequence-based identification, which demonstrated that conventional identification had the highest genus-level (84%) but lowest species-level (3%) identification rates compared to VITEK (59 and 52%, respectively) and Bruker (52 and 36%) using VITEK extractions. Taken together, our findings suggest both MALDI-TOF systems can supplement conventional mold identification to optimize identification rates with species-level distinction. IMPORTANCE: Mold identification using matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) remains uncommon in clinical laboratories. Contributing concerns include limited genus/species spectra in the MALDI-TOF MS libraries, varying success rates in the literature regarding extraction methods and instrumentation, and the lack of practical performance evaluations using early mold colony growth, which would be used in a clinical mycology laboratory. This study used multiple approaches to improve our understanding of the clinical utility and performance of MALDI-TOF MS mold identification.

10 October 2025 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
AYAOI YOGO
AOI YOGO
ESElie Saade
Elie Saade
EREric M. Ransom
Eric M. Ransom
BWBrigid M. Wilson
Brigid M. Wilson
TJTimothy C. Jenkins
Timothy C. Jenkins
LHLeila Hojat
Leila Hojat
Objective: To evaluate the impact of implementation of a conditional reflex urine culturing strategy on urine culture rates, antimicrobial use, and clinical outcomes in hospitalized adults. Design: Pre-post quasi-experimental study. Setting: Emergency departments and inpatient units within a large, integrated healthcare system in Northeast Ohio, comprising 10 medical centers. Patients: Adult patients with a urine culture ordered from June 1, 2018, to May 31, 2023. Methods: A system-wide intervention was implemented on June 1, 2020, requiring urinalysis (UA) with pyuria findings to trigger a urine culture order. We compared urine culture rates, antimicrobial use (measured by days of therapy [DOT] and days of antimicrobial spectrum coverage [DASC]), and clinical outcomes between pre-and post-intervention periods. Results: The intervention resulted in an 85.4% reduction in urine culture rates (0.54 vs 3.71 per 100 patient days). Antimicrobial use decreased, with DOT per 100 patient days dropping by 11.5% and DASC/DOT by 16.1%. No significant differences were observed in Clostridioides difficile infection rate, subsequent bloodstream infections with urinary pathogens, or mortality between pre- and post-intervention groups. Conclusions: A conditional reflex urine culturing strategy implemented as part of a diagnostic stewardship framework reduced urine culture and antimicrobial use without adverse clinical outcomes. This highlights the potential of diagnostic stewardship to optimize antimicrobial use in hospitalized adults.

2 September 2025 in ASM Case Reports
Verified
Journal Article
Open access
DSDaniella E. Sankovic
Daniella E. Sankovic
AHAlyssa L. Hubal
Alyssa L. Hubal
MAMandy A. Alhajj
Mandy A. Alhajj
NANeil W. Anderson
Neil W. Anderson
SCSree Cherian
Sree Cherian
EREric M. Ransom
Eric M. Ransom
Background: Hansen’s disease, also known as leprosy, is an infection of the skin and peripheral nerves that is rarely encountered in the United States. This case describes a patient without recent international travel who achieved a successful therapeutic outcome using a new monthly multidrug treatment regimen recommended by the National Hansen’s Disease Program. Case Summary: A 78-year-old male presented with peripheral neuropathy, widespread macular erythematous rash involving face, trunk, extremities, bilateral hand edema, and oligoarticular unilateral elbow and knee bursitis. A skin biopsy revealed a lymphohistiocytic infiltrate in the presence of acid-fast bacilli (AFB) without globi. No AFB were recovered from tissue culture. Direct molecular testing from the skin biopsy detected Mycobacterium leprae . The patient had no recent risk factors for contracting Hansen’s disease, other than travel to Florida. The patient was treated with a monthly multidrug therapy regimen of rifampin, moxifloxacin, and minocycline (RMM) and had successful clinical reduction in disease manifestations. Conclusion: Hansen’s disease is uncommon in the United States, especially in the Midwest. However, providers should include Hansen’s disease on their differential even if recent travel was only domestic, particularly to Florida. In addition, the monthly multidrug treatment regimen RMM is an effective monthly treatment alternative, especially for patients with concerns of intolerance to first-line drugs.

12 August 2026 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
AYAOI YOGO
AOI YOGO
JKJ. Krishnan
J. Krishnan
GLG. R. Lewin
G. R. Lewin
LHL. S. Hojat
L. S. Hojat
ERE. M. Ransom
E. M. Ransom
Staphylococcus lugdunensis is a common skin commensal. However, S. lugdunensis found in multiple blood culture sets is concerning for life-threatening bacteremia. When a single set is positive, the National Healthcare Safety Network classifies S. lugdunensis as a common commensal (contaminant), while multiple publications found bacteremia and suggested an Infectious Diseases (ID) consultation. Here, a retrospective review spanning 9 years at a large health system evaluated the clinical significance of a single-positive S. lugdunensis blood culture when multiple cultures were collected. S. lugdunensis was found in blood cultures from 137 patients, who were stratified into single ( n = 91) and multiple ( n = 46) set-positive groups. The single-positive group was more likely to be deemed contaminants by clinicians, less likely to have a diagnosis of endocarditis or catheter-related bloodstream infection, and less likely to have an intravascular device ( P < 0.01). Treatment occurrence and duration were also statistically different ( P < 0.01). Single-positive cultures were statistically more likely to be polymicrobial ( P = 0.04). Additionally, each case was reclassified as significant bacteremia, indeterminate bacteremia, or contamination using the Souvenir criteria. In single-positive cultures, significant bacteremia occurred less often (12.1% vs. 43.5%, P < 0.01), while contamination was more common (81.3% vs. 32.6%, P < 0.01). Of note, nearly all significant bacteremia cases involved an intravascular device (96.8%). Taken together, these findings suggest single-positive S. lugdunensis blood cultures are often contaminants, but certain clinical features, including intravascular devices, strongly predict bacteremia. IMPORTANCE: A single-positive blood culture set with Staphylococcus lugdunensis can be difficult to distinguish between contamination and bacteremia. Conflicting clinical guidance has added to the confusion and emphasizes the need for additional studies. Our results suggest a single-positive S. lugdunensis blood culture set often reflects contamination and polymicrobial cultures, whereas multiple-positive sets strongly predict significant bacteremia. We also identified predictors of significant bacteremia, such as the presence of an intravascular device, emphasizing the need to incorporate additional metrics into clinical decision-making algorithms. Our findings underscore the role of clinical judgment when S. lugdunensis is recovered from a blood culture. Taken together, the proposed practice for the microbiology laboratory is to include a contamination comment on the report of a single-positive S. lugdunensis blood culture set and to recommend an infectious disease consultation for clinical adjudication.

7 April 2026 in Microbiology Spectrum
Verified
Journal Article
Open access
MSMichael Snyder
Michael Snyder
ALAshley Lawrence
Ashley Lawrence
JRJane Reese
Jane Reese
DWDavid Wald
David Wald
NANeil Anderson
Neil Anderson
EREric Ransom
Eric Ransom
Sterility testing of cellular and gene therapy products is required to ensure safe infusion for the recipient. Sterility testing is often performed using broth-based media per the biopharmaceutical compendial USP method. Automated blood culture systems have emerged as a potential alternative method, but data remain limited. It also remains unclear whether different cellular and gene therapy product formulations inhibit microbial growth during sterility testing, which could lead to false-negative sterility results. This study evaluated the ability to perform sterility testing using the BacT/Alert Virtuo automated blood culture system, BacT/Alert FA plus (aerobic) and FN plus (anaerobic) blood culture bottles, and two product formulations: (i) Plasmalyte-A + 2.5% human serum albumin (HSA) and (ii) Plasmalyte-A + 5% HSA + 5% dimethyl sulfoxide (DMSO). Contrived specimens were created using either formulation or a saline-only growth control inoculated with Staphylococcus aureus , Bacillus subtilis , Pseudomonas aeruginosa , Clostridium sporogenes , Candida albicans , or Aspergillus brasiliensis . Contrived specimens were prepared in blood culture sets consisting of an aerobic bottle and an anaerobic bottle and incubated for a maximum of 14 days. Bottles flagging positive underwent culture-dependent microbial identification using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) for bacteria and yeast or using macroscopic and microscopic identification for filamentous fungi. The automated blood culture system method correctly flagged all contrived blood culture sets within 72 h, demonstrating no inhibitory effect on microbial recovery from either formulation. Note, both aerobic and anaerobic bottles were necessary to detect microbes with different growth preferences (e.g., strict aerobes and obligate anaerobes). Another important finding was that the addition of calcofluor staining and a Sabouraud dextrose agar (SDA) plate improved early mold detection when no organisms were detected by the initial Gram stain from a positive blood culture. Taken together, our findings suggest that two standard cellular and gene therapy product formulations do not interfere with sterility testing in an automated blood culture detection system. IMPORTANCE: Cellular and gene therapy products have emerged in recent years as an important treatment modality at large academic medical centers; however, these products must be tested for microbial contamination to ensure product safety. Compared to the gold standard, agar-based solid media method, automated blood culture systems have emerged as a potential alternative method of sterility testing. Here, we evaluated the ability of an automated blood culture detection system (BacT/Alert Virtuo) to reliably detect diverse microorganisms, ranging from bacteria to mold, in two standard cellular and gene therapy product formulations. Our results support current evidence that the use of automated blood culture detection systems is a reliable alternative method of sterility testing for different formulations of cellular and gene therapy products.